AstraZeneca PLCAZNCF

A global biopharmaceutical company focused on developing and commercializing prescription medicines across oncology, cardiovascular, renal, metabolism, respiratory, immunology, and rare diseases. The company generates tens of billions in annual revenue from a portfolio of blockbuster drugs and an extensive late-stage pipeline, with operations spanning the U.S., Europe, and emerging markets. Investors track its clinical trial results, regulatory approvals, and patent lifecycle exposure, which materially influence revenue growth and long-term valuation.